EP0873132A4 - PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO - Google Patents

PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO

Info

Publication number
EP0873132A4
EP0873132A4 EP96940479A EP96940479A EP0873132A4 EP 0873132 A4 EP0873132 A4 EP 0873132A4 EP 96940479 A EP96940479 A EP 96940479A EP 96940479 A EP96940479 A EP 96940479A EP 0873132 A4 EP0873132 A4 EP 0873132A4
Authority
EP
European Patent Office
Prior art keywords
huntington
interacts
antibodies
protein
gene product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96940479A
Other languages
German (de)
French (fr)
Other versions
EP0873132A1 (en
Inventor
Michael Kalchman
Michael R Hayden
Paul Goldberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of EP0873132A1 publication Critical patent/EP0873132A1/en
Publication of EP0873132A4 publication Critical patent/EP0873132A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
EP96940479A 1995-11-17 1996-11-15 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO Withdrawn EP0873132A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US688295P 1995-11-17 1995-11-17
US6882P 1995-11-17
PCT/US1996/018370 WO1997018825A1 (en) 1995-11-17 1996-11-15 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO

Publications (2)

Publication Number Publication Date
EP0873132A1 EP0873132A1 (en) 1998-10-28
EP0873132A4 true EP0873132A4 (en) 2002-09-18

Family

ID=21723087

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96940479A Withdrawn EP0873132A4 (en) 1995-11-17 1996-11-15 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO

Country Status (3)

Country Link
EP (1) EP0873132A4 (en)
CA (1) CA2238075A1 (en)
WO (1) WO1997018825A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235879B1 (en) * 1995-11-17 2001-05-22 University Of British Columbia Apoptosis modulators that interact with the Huntington's disease gene
CA2216057A1 (en) * 1997-09-19 1999-03-19 Ridha Joober Polymorphic cag repeat-containing gene, diagnosis of psychiatric diseases and therapeutic uses thereof
US7595199B1 (en) * 1998-07-31 2009-09-29 Max-Planck-Gesellschaft zur Förderung der Wissenchaften e.V. Method of detecting amyloid-like fibrils or protein aggregates
FR2797055B1 (en) * 1999-07-29 2003-10-03 Fond Jean Dausset Ceph METHOD FOR SCREENING MOLECULES FOR THE TREATMENT OF HUNTINGTON'S DISEASE
CN1315403A (en) * 2000-03-28 2001-10-03 上海博德基因开发有限公司 Polypeptide-human Huntingtn Protein interaction protein 15 and polynucleotide for coding it
US20020133841A1 (en) * 2000-12-11 2002-09-19 Leviten Michael W. Transgenic mice containing huntingtin interacting protein gene disruptions
US7227007B2 (en) 2000-12-28 2007-06-05 Asahi Kasei Pharma Corporation NF-κB activating gene
US7332290B2 (en) 2001-08-02 2008-02-19 The Regents Of The University Of Michigan Dectection of AMACR cancer markers in urine
US7700293B2 (en) 2001-08-02 2010-04-20 The Regents Of The University Of Michigan Expression profile of prostate cancer
US7229774B2 (en) 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
US20040092465A1 (en) * 2002-11-11 2004-05-13 Isis Pharmaceuticals Inc. Modulation of huntingtin interacting protein 1 expression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2116280A1 (en) * 1993-03-05 1994-09-06 Marcy E. Macdonald Huntingtin dna, protein and uses thereof
US5538844A (en) * 1993-03-23 1996-07-23 The General Hospital Corporation Transport protein gene from the Huntington's disease region
WO1994024279A2 (en) * 1993-04-16 1994-10-27 Johanna Eugenie Bergmann Agents for the prevention and treatment of huntington's disease and other neurological disorders

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LI ET AL: "A huntungtin-associated protein enriched in brain with implications fir pathology", NATURE, vol. 378, 23 November 1995 (1995-11-23), pages 398 - 402, XP001084392 *
ROSS C A ET AL: "HUNTINGTON'S DISEASE (HD): INVOLVEMENT OF THE HD PROTEIN AND IDENTIFICATION OF A CDNA CODING FOR AN ASSOCIATED PROTEIN (HAP-1)", AMERICAN JOURNAL OF HUMAN GENETICS, UNIVERSITY OF CHICAGO PRESS, CHICAGO,, US, vol. 57, no. 4, 1 October 1995 (1995-10-01), pages 41, XP000647669, ISSN: 0002-9297 *
See also references of WO9718825A1 *

Also Published As

Publication number Publication date
EP0873132A1 (en) 1998-10-28
CA2238075A1 (en) 1997-05-29
WO1997018825A1 (en) 1997-05-29

Similar Documents

Publication Publication Date Title
AU4426296A (en) G protein coupled receptor protein, production, and use thereof
HUP9801639A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
IL113708A0 (en) Protein production and protein delivery
AU6255096A (en) Pegylated modified proteins
AU3274995A (en) Fibrin-binding peptides, dna coding therefor and uses thereof
IL121243A0 (en) Insecticidal protein toxins from photorhabdus
AU1235392A (en) Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof
EP0805161A4 (en) (1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody
EP0779035A4 (en) Modified whey protein
HK1010153A1 (en) Recombinant human alpha-fetoprotein and uses thereof.
AU6550894A (en) Human serotonin receptors, dna encoding the receptors, and uses thereof
EP0873132A4 (en) PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO
AU7652898A (en) Uncoupling protein homologue: ucp 3
EP0669396A4 (en) Novel polypeptide and dna coding for the same.
ZA969402B (en) Novel oligopeptides, the preparation and use thereof.
AU1694195A (en) cDNA and genomic clones encoding human my opiate receptor and the purified gene product
EP0856005A4 (en) The aiolos gene
HUP9801680A3 (en) Peptides and remedy for autoimmune diseases comprising the same
EP0729975A4 (en) Ecdn protein and dna coding for the same
EP0841393A4 (en) HUMAN GALECTIN-4-LIKE PROTEIN AND cDNA ENCODING THE SAME
EP0600278A3 (en) Glutamate receptor protein and gene coding the same.
EP0617125A3 (en) A novel transport protein gene from the huntington's disease region.
AU1693995A (en) Phosphacan, nucleic acids encoding thereof and antibodies thereto
AU8752401A (en) A novel polypeptide, a humain protein synthesis initiation factor sub-unit 2 beta 16.5 and the polynucleotide encoding the polypeptide
ZA964358B (en) "DNA encoding cellular homologue of the SV40 Large T antigen".

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980617

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB

RIN1 Information on inventor provided before grant (corrected)

Inventor name: GOLDBERG, PAUL

Inventor name: HAYDEN, MICHAEL, R.

Inventor name: KALCHMAN, MICHAEL

A4 Supplementary search report drawn up and despatched

Effective date: 20020805

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020601